fashion -WSS

fashion

author：leisure time 2025-09-30 17:27:01 - browse：777

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

“I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Coercive sterilizations revealed by STAT prompt outrage

leisure time

WSS

American taxpayers paid $1.8 trillion in health care costs in 2022

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Male doctors called my cancer incurable. A female doctor showed it wasn't

Medicare Advantage coverage denials need scrutiny, senators say

My daughter's legacy lives on through her writing, phage therapy

Study suggests new cause of Down syndrome: cells linked to aging

entertainment

fashion

explore

Malaria cases in Florida and Texas: Here’s what you need to know

California wildfire smoke linked to 52,000 early deaths, study says

At least 13 dead in Texas as scorching temps continue

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Hollywood unions extend contract negotiations for actors

Statins may not be needed by millions of people, study suggests

Alkermes shareholders re

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Trump demands the U.S. pay no more for drugs than other countries … again

Moderna says combo Covid

explore

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

5 takeaways from STAT's examination of Zynex Medical

At JPM 2024, hospital systems pitch financial strength to investors

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

leisure time

Wikipedia

focus

focus